A 2015 Scientific Reports study comparing six commercial kits found inter-assay variations of 5-20%, highlighting the need for consistent methodology when tracking changes over time
Transl Neurodegener 14(1):67
The presence of diabetes, atherosclerosis, and heart disease are additional risk factors
Evidence from murine models demonstrates that SCFA supplementation consistently improves liver health, supporting the therapeutic potential of SCFA-based interventions for human liver disease and warranting clinical investigation (167, 168)
Thats a big change from an era when many people with higher BMIs felt stigmatized in doctors offices and, as a result, some avoided medical care
Information provided by Blue Cross and Blue Shield of Illinois is for informational and educational purposes only and is not a substitute for the independent medical judgment of a physician or other health care provider, nor is the information presented intended to replace or supersede any requirements set forth in your contract with BCBSIL
